Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

Intensive glucose control increased mortality and did not prevent cardiovascular events in type 2 diabetes.

Sherifali D.

Evid Based Nurs. 2009 Jan;12(1):12-3. doi: 10.1136/ebn.12.1.13. No abstract available.

PMID:
19103831
[PubMed]
2.

Intensive glucose control increased mortality and did not prevent cardiovascular events in type 2 diabetes.

Montori VM, Malaga G.

ACP J Club. 2008 Sep 16;149(3):6-7. No abstract available.

PMID:
18783183
[PubMed]
3.

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.

Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N.

Lancet. 2009 May 23;373(9677):1765-72. doi: 10.1016/S0140-6736(09)60697-8.

PMID:
19465231
[PubMed - indexed for MEDLINE]
4.

Intensive glucose control increased mortality and did not prevent cardiovascular events in type 2 diabetes.

Montori VM, Malaga G.

Evid Based Med. 2008 Dec;13(6):168-9. doi: 10.1136/ebm.13.6.169. No abstract available.

PMID:
19043027
[PubMed]
5.

Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.

Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Valle TT, Eriksson JG, Tuomilehto J; Finnish Diabetes Prevention Study Group.

PLoS One. 2009 May 21;4(5):e5656. doi: 10.1371/journal.pone.0005656.

PMID:
19479072
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Is it possible to reduce cardiovascular risk with glucose-lowering approaches?

Gerstein HC.

Nat Rev Endocrinol. 2009 May;5(5):270-5. doi: 10.1038/nrendo.2009.49. Review.

PMID:
19444260
[PubMed - indexed for MEDLINE]
7.

Trials review: cardiovascular outcome with intensive glycemic control and implications for patients with type 2 diabetes.

Brown SH, Abdelhafiz AH.

Postgrad Med. 2009 Sep;121(5):31-41. doi: 10.3810/pgm.2009.09.2050. Review.

PMID:
19820272
[PubMed - indexed for MEDLINE]
8.

[Treatment of diabetes in metabolic syndrome].

Pelikánova T.

Vnitr Lek. 2009 Jul-Aug;55(7-8):637-45. Review. Czech.

PMID:
19731868
[PubMed - indexed for MEDLINE]
9.

Antidiabetic agents and cardiovascular risk in type 2 diabetes.

Zarich SW.

Nat Rev Endocrinol. 2009 Sep;5(9):500-6. doi: 10.1038/nrendo.2009.150. Epub 2009 Jul 28. Review.

PMID:
19636325
[PubMed - indexed for MEDLINE]
10.

Glycaemic control and cardiovascular morbi-mortality: the contribution of the 2008 studies.

Cugnet-Anceau C, Bauduceau B.

Ann Endocrinol (Paris). 2009 Mar;70(1):48-54. doi: 10.1016/j.ando.2008.12.008. Epub 2009 Feb 3. Review.

PMID:
19193363
[PubMed - indexed for MEDLINE]
11.

Glycemic targets for patients with type 2 diabetes mellitus.

Hamnvik OP, McMahon GT.

Mt Sinai J Med. 2009 Jun;76(3):227-33. doi: 10.1002/msj.20117.

PMID:
19421966
[PubMed - indexed for MEDLINE]
Free Article
12.

Megatrials in type 2 diabetes. From excitement to frustration?

Del Prato S.

Diabetologia. 2009 Jul;52(7):1219-26. doi: 10.1007/s00125-009-1352-5. Epub 2009 Apr 17. Review.

PMID:
19373446
[PubMed - indexed for MEDLINE]
13.

Potential of glucose-lowering drugs to reduce cardiovascular events.

Zarich SW.

Curr Diab Rep. 2009 Feb;9(1):87-94. Review.

PMID:
19192430
[PubMed - indexed for MEDLINE]
14.

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

Beulens JW, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA, Grobbee DE, Stolk RP; AdRem project team; ADVANCE management committee.

Diabetologia. 2009 Oct;52(10):2027-36. doi: 10.1007/s00125-009-1457-x. Epub 2009 Jul 25.

PMID:
19633827
[PubMed - indexed for MEDLINE]
15.

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.

Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, Poulter N, Lip GY, Patel A; ADVANCE Collaborative Group.

Eur Heart J. 2009 May;30(9):1128-35. doi: 10.1093/eurheartj/ehp055. Epub 2009 Mar 11.

PMID:
19282274
[PubMed - indexed for MEDLINE]
Free Article
16.

[Intensive blood glucose control in patients with type 2 diabetes lowers the risk of cardiovascular events (very) moderately].

Steurer J.

Praxis (Bern 1994). 2009 Oct 7;98(20):1169-70. doi: 10.1024/1661-8157.98.20.1169. German. No abstract available.

PMID:
19809982
[PubMed]
17.

ACP journal club. Intensive glucose control increased mortality and did not prevent CV events compared with standard glucose control in type 2 diabetes.

Grubina R, Smith SA.

Ann Intern Med. 2011 May 17;154(10):JC5-02. doi: 10.7326/0003-4819-154-10-201105170-02002. No abstract available.

PMID:
21576520
[PubMed]
18.

Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.

Roman G, Hancu N.

Horm Metab Res. 2009 Feb;41(2):116-22. doi: 10.1055/s-0028-1128144. Epub 2009 Feb 12. Review.

PMID:
19214921
[PubMed - indexed for MEDLINE]
19.

Serum phosphorus and cardiovascular mortality in type 2 diabetes.

Chonchol M, Dale R, Schrier RW, Estacio R.

Am J Med. 2009 Apr;122(4):380-6. doi: 10.1016/j.amjmed.2008.09.039.

PMID:
19332233
[PubMed - indexed for MEDLINE]
20.

Preoperative oral glucose tolerance testing in vascular surgery patients: long-term cardiovascular outcome.

van Kuijk JP, Dunkelgrun M, Schreiner F, Flu WJ, Galal W, van Domburg RT, Hoeks SE, van Gestel YR, Bax JJ, Poldermans D.

Am Heart J. 2009 May;157(5):919-25. doi: 10.1016/j.ahj.2009.02.011.

PMID:
19376322
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk